How artificial intelligence can power clinical development

McKinsey&CompanyChris Anagnostopoulos, David Champagne, Thomas Devenyns, Alex Devereson, Heikki Tarkkila,November 22, 2023

Artificial intelligence is accelerating drug discovery. If clinical development fails to keep pace, the benefits to patients will be delayed.

Read more at McKinsey&Company

Related headlines

A year after launching, ChatGPT is already changing medicine

Axios11/29/2023

The Upside of Disruption: Innovation

NEJM Catalyst09/08/2023

How Epic is using AI to change the way EHRs work

Healthcare IT News11/28/2023